IL75567A0 - Substituted 3,4-diamino-1,2,5-thiadiazoles,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted 3,4-diamino-1,2,5-thiadiazoles,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL75567A0
IL75567A0 IL75567A IL7556785A IL75567A0 IL 75567 A0 IL75567 A0 IL 75567A0 IL 75567 A IL75567 A IL 75567A IL 7556785 A IL7556785 A IL 7556785A IL 75567 A0 IL75567 A0 IL 75567A0
Authority
IL
Israel
Prior art keywords
thiadiazoles
diamino
substituted
preparation
pharmaceutical compositions
Prior art date
Application number
IL75567A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Priority to IL89014A priority Critical patent/IL89014A/xx
Publication of IL75567A0 publication Critical patent/IL75567A0/xx
Priority to IL89014A priority patent/IL89014A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL75567A 1984-06-22 1985-06-19 Substituted 3,4-diamino-1,2,5-thiadiazoles,their preparation and pharmaceutical compositions containing them IL75567A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL89014A IL89014A (en) 1984-06-22 1985-06-19 Substituted ethane-diimidamide derivatives and their preparation
IL89014A IL89014A0 (en) 1984-06-22 1989-01-20 Substituted ethane-diimidamide derivatives and their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/623,588 US4644006A (en) 1984-06-22 1984-06-22 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity

Publications (1)

Publication Number Publication Date
IL75567A0 true IL75567A0 (en) 1985-10-31

Family

ID=24498651

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75567A IL75567A0 (en) 1984-06-22 1985-06-19 Substituted 3,4-diamino-1,2,5-thiadiazoles,their preparation and pharmaceutical compositions containing them

Country Status (33)

Country Link
US (1) US4644006A (US06373033-20020416-M00035.png)
JP (2) JPS6118775A (US06373033-20020416-M00035.png)
KR (1) KR900004321B1 (US06373033-20020416-M00035.png)
AR (1) AR240935A1 (US06373033-20020416-M00035.png)
AT (1) AT390790B (US06373033-20020416-M00035.png)
AU (2) AU580605B2 (US06373033-20020416-M00035.png)
BE (1) BE902724A (US06373033-20020416-M00035.png)
CA (2) CA1267412A (US06373033-20020416-M00035.png)
CH (1) CH665210A5 (US06373033-20020416-M00035.png)
CS (1) CS257276B2 (US06373033-20020416-M00035.png)
DD (1) DD240889A5 (US06373033-20020416-M00035.png)
DE (1) DE3522101A1 (US06373033-20020416-M00035.png)
DK (1) DK282885A (US06373033-20020416-M00035.png)
ES (2) ES8702902A1 (US06373033-20020416-M00035.png)
FI (1) FI852405L (US06373033-20020416-M00035.png)
FR (1) FR2566406B1 (US06373033-20020416-M00035.png)
GB (2) GB2161157B (US06373033-20020416-M00035.png)
GR (1) GR851514B (US06373033-20020416-M00035.png)
HU (1) HU193992B (US06373033-20020416-M00035.png)
IE (2) IE57937B1 (US06373033-20020416-M00035.png)
IL (1) IL75567A0 (US06373033-20020416-M00035.png)
IT (1) IT1190372B (US06373033-20020416-M00035.png)
LU (1) LU85969A1 (US06373033-20020416-M00035.png)
NL (1) NL8501766A (US06373033-20020416-M00035.png)
NO (1) NO161856C (US06373033-20020416-M00035.png)
NZ (1) NZ212403A (US06373033-20020416-M00035.png)
OA (1) OA08039A (US06373033-20020416-M00035.png)
PT (1) PT80684B (US06373033-20020416-M00035.png)
SE (1) SE464305B (US06373033-20020416-M00035.png)
SU (1) SU1537136A3 (US06373033-20020416-M00035.png)
YU (2) YU45725B (US06373033-20020416-M00035.png)
ZA (1) ZA854710B (US06373033-20020416-M00035.png)
ZW (1) ZW10385A1 (US06373033-20020416-M00035.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535227A4 (en) * 1990-05-29 1993-08-18 Nippon Soda Co., Ltd. N-substituted heterocyclic amidine derivative
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
FI76795C (fi) * 1979-09-04 1988-12-12 Bristol Myers Co Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 3,4-disubstituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanprodukter.
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
EP0045155B1 (en) * 1980-07-30 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives
EP0060730A3 (en) * 1981-03-18 1982-12-08 Imperial Chemical Industries Plc Bicyclic derivatives
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
US4528378A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4588826A (en) * 1982-03-29 1986-05-13 Bristol-Myers Company Ethanediimidamide intermediates
US4517366A (en) * 1982-03-29 1985-05-14 Bristol-Myers Company Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4528377A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
ES8404683A1 (es) * 1982-03-29 1984-05-16 Bristol Myers Co Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina.
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FI832519L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
JPS5978171A (ja) * 1982-10-26 1984-05-04 Ikeda Mohandou:Kk 複素環式化合物
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles

Also Published As

Publication number Publication date
FI852405L (fi) 1985-12-23
DD240889A5 (de) 1986-11-19
BE902724A (fr) 1985-12-23
IE58261B1 (en) 1993-08-25
AU4392085A (en) 1986-01-02
AU580605B2 (en) 1989-01-19
ZA854710B (en) 1986-02-26
YU105185A (en) 1987-12-31
AT390790B (de) 1990-06-25
AR240935A1 (es) 1991-03-27
FR2566406A1 (fr) 1985-12-27
CH665210A5 (de) 1988-04-29
CA1267412A (en) 1990-04-03
IE57937B1 (en) 1993-05-19
JPS61186369A (ja) 1986-08-20
GB2161157A (en) 1986-01-08
GB8716149D0 (en) 1987-08-12
KR900004321B1 (ko) 1990-06-22
GB2161157B (en) 1988-08-10
NO161856B (no) 1989-06-26
PT80684A (en) 1985-07-01
FR2566406B1 (fr) 1988-01-29
KR860000275A (ko) 1986-01-27
SE8503110D0 (sv) 1985-06-20
CS257276B2 (en) 1988-04-15
ATA185885A (de) 1989-12-15
CS424785A2 (en) 1987-09-17
AU614331B2 (en) 1991-08-29
CA1297875C (en) 1992-03-24
HU193992B (en) 1987-12-28
YU45822B (sh) 1992-07-20
ES8702902A1 (es) 1987-01-16
YU45725B (sh) 1992-07-20
HUT42087A (en) 1987-06-29
IT8521217A0 (it) 1985-06-20
IT1190372B (it) 1988-02-16
NZ212403A (en) 1989-04-26
OA08039A (fr) 1987-01-31
JPS6118775A (ja) 1986-01-27
GB8515749D0 (en) 1985-07-24
LU85969A1 (fr) 1986-01-24
ES8702881A1 (es) 1987-01-16
DE3522101A1 (de) 1986-01-02
ZW10385A1 (en) 1986-02-05
ES551506A0 (es) 1987-01-16
GB2192884A (en) 1988-01-27
IE851557L (en) 1985-12-22
DK282885A (da) 1985-12-23
ES544409A0 (es) 1987-01-16
AU2977589A (en) 1989-06-01
SU1537136A3 (ru) 1990-01-15
DK282885D0 (da) 1985-06-21
US4644006A (en) 1987-02-17
YU102587A (en) 1988-02-29
SE8503110L (sv) 1985-12-23
NO852519L (no) 1985-12-23
GR851514B (US06373033-20020416-M00035.png) 1985-11-25
FI852405A0 (fi) 1985-06-17
NL8501766A (nl) 1986-01-16
NO161856C (no) 1989-10-04
GB2192884B (en) 1988-08-10
AR240935A2 (es) 1991-03-27
PT80684B (en) 1987-05-08
SE464305B (sv) 1991-04-08

Similar Documents

Publication Publication Date Title
IL82671A0 (en) 1,5-diaryl-3-substituted-pyrazoles,their preparation and pharmaceutical compositions containing them
IL73706A0 (en) 2,2'-iminobisethanol derivatives,their preparation and pharmaceutical compositions containing them
IL76405A0 (en) 1,3-diacyl-2-oxyindole derivatives,their preparation and pharmaceutical compositions containing them
IL77004A0 (en) 5-amino-4-hydroxyvaleryl derivatives,their manufacture and pharmaceutical compositions containing them
IL65076A (en) 3,4-dihydro-5h-2,3-benzo-diazepine derivatives,their preparation and pharmaceutical compositions containing them
IL90864A0 (en) Substituted 1,7-annelated 1h-indazoles,their preparation and pharmaceutical compositions containing them
IL84832A (en) 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5- tetrahydropyridazin-3- ones, their preparation and pharmaceutical compositions containing them
ZA862141B (en) Substituted 1,8-naphthyridinones,processes for their preparation and pharmaceutical compositions containing them
IL76823A0 (en) 1,2,4-triazolo-carbamates,their preparation and pharmaceutical compositions containing them
IL75720A0 (en) Morpholinol compounds,their preparation and pharmaceutical compositions containing them
IL75966A0 (en) 3-substituted-1-aminoalkyl-1h-indoles,their preparation and pharmaceutical compositions containing them
EP0180190A3 (en) 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same
IL74270A0 (en) 1,2,4-triazole derivatives,their preparation and pharmaceutical compositions containing them
IL64563A (en) 1,2,5-oxadiazole 3,4-dicarboxamide-2-oxide derivatives,their preparation and pharmaceutical compositions containing them
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
IL76312A (en) Xenocoumacins and derivatives thereof,their preparation and pharmaceutical compositions containing them
EP0159652A3 (en) 4-phenylphthalazine derivatives, their preparation and pharmaceutical compositions containing them
DE3573784D1 (en) Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
DE3561808D1 (en) Phenylnonatetraenic-acid derivatives, their preparation and pharmaceutical compositions containing them
IL73278A0 (en) Pharmaceutical compositions containing 1,2-dithiolan derivatives,certain such derivatives and their preparation
IL75636A0 (en) Cephalosporins,their preparation and pharmaceutical compositions containing them
IL77055A0 (en) Polycyclic compounds,their preparation and pharmaceutical compositions containing them
IL76166A0 (en) Cyclimmonium salts,their preparation and pharmaceutical compositions containing them
IL77426A (en) 2,6-dimethyl-8alpha-pivaloyl-amino-9,10-didehydro-ergoline,its production and pharmaceutical compositions containing it
IL74006A0 (en) Tricyclic compounds,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RH Patent void